Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
82 Cards in this Set
- Front
- Back
Achondroplasia (etiology and 3 main symptoms)
|
FGFR3 point mutation (gene that normally slows bone growth, the abnormal protein is more active than normal so it suppresses)
Short bones, spinal stenosis, foramen magnum stenosis |
|
Bisphophonates
|
Inhibit osteoclasts
Treatment for OI |
|
Osteogenesis imperfecta and gene mutations
|
Usually type I collagen
Phenotype is milder if mutation is closer to amino terminus |
|
Osteogenesis imperfecta: two classifications
|
Type I: normal collagen but half normal amount
Type II-IV: abnormal collagen |
|
Blount's disease (etiology and main symptom)
|
Disordered ossification of medial aspect of proximal tibial physis, epiphysi, and metaphysis so bone grows crooked
Genu varum |
|
Mucopolysaccharidoses
|
Lysosomal enzyme deficiency for degradation of glycosaminoglycans (GAGs)
Autosomal recessive More GAGs means thickening of tissues and GAG excretion in urine |
|
Morquio
|
Mucopolysaccharidosis
Keratan sulfate degradation blocked KS is primarily in cornea and cartilage Spinal deformity, growth retardation, genu valgum |
|
Features of synovium (6)
|
Loose connective tissue w/ lymphatics
Underneath synovial membrane No basement membrane allowing for joints to swell quickly Highly vascular Fluid has hyaluronic acid Upon damage becomes hyperplastic |
|
Articular cartilage features (2, composition 4, and destruction 2)
|
Hyaline cartilage acts as shock absorber
Avascular Composed of collagen II, water, proteoglycans, chondrocytes Destruction by matrix breakdown or indigenous cells |
|
Osteoarthritis
|
Erosion of articular cartilage
-> synovial fluid intrudes into bone -> bone is replaced by inflammatory tissue -> chondrocytes stop producing collagen II and instead favor catabolic activity |
|
Avascular necrosis (2)
|
Results form ischemia -> infarct
New bone replaces infarct by creeping substitution |
|
Rheumatoid arthritis (2 signs)
|
Chronic inflammatory disease mediated by CD4 T cells
-> destruction of articular cartilage Pannus formation Joint ankylosis |
|
Pannus
|
Inflammatory, fibrotic membrane that fills joint space
Derived from synovium |
|
Gout and gouty arthritis
|
Inflammatory arthritis caused by deposition of urate crystals in joints
|
|
Infectious arthritis (caused by?)
|
Mainly caused by TB or Lyme
Hematogenous spread or contiguous extension |
|
Ganglion and synovial cysts
|
Ganglion - fluid-filled swelling from tissue around joint
Synovial (Baker's) - herniation of synovium through joint capsule into soft tissue |
|
Osteoclasts (lineage and 4 characteristics)
|
Lineage: hematopoietic macrophage/monocyte lineage
Giant, multinucleated, extracellular lysosomes, ruffled border |
|
Osteoclast differentiation
|
RANKL expressed on osteoblasts and marrow stromal cells
RANK expressed on preosteoclasts M-CSF promotes interaction and Osteoprotegerin (OPG) blocks |
|
Osteoblasts (lineage and 4 characteristics)
|
Lineage: mesenchymal marrow stem cells
Secrete bone matrix proteins, regulate osteoclasts, mononuclear, cuboidal |
|
Osteoblast differentiation
|
BMP and Wnt stimulates osteoprogenitor cell -> preosteoblast
|
|
Osteocytes (2)
|
Trapped osteoblast
Secretes sclerostin which inhibits osteoblast bone formation |
|
Bone formation markers (3)
|
Alkaline phosphatase (mineralizes bone)
Procollagen peptides Osteocalcin |
|
Bone resorption markers (2)
|
Urinary calcium
Hydroxyproline |
|
Osteoporosis (definition and risk factors6)
|
Reduced bone mass and strength
Age, thin/small, hereditary, caucasion, tobacco/alcohol, early menopause |
|
Osteoporosis treatments (4)
|
Bisphosphonates: inhibit bone resorption
Hormonal replacement therapy for prevention Parathyroid hormone - stimulates bone formation Selective estrogen receptor modulators - estrogens reduce bone resorption |
|
Vitamin D deficiency (leads to 4; and 2 causes
|
Leads to decreased calcium absorption and hypocalcemia; rickets in children and osteomalacia in adults
Causes: dietary or malabsorption |
|
Neoplasm (6 clinical features)
|
Tumor (swelling) benign or malignant
Features: fever, anemia, anorexia, cachexia, ectopic hormone production, pathology bone fracture |
|
Neoplasia nomenclature: epithelial tumors
|
Squamous origin: benign = papilloma; malignant = carcinoma
Glandular origin: benign = adenoma; malignant = adenocarcinoma |
|
Neoplasia nomenclature: mesenchymal tumors
|
Benign: -oma (eg lipoma)
Malignant: sarcoma (liposarcoma) |
|
Teratoma (benign or malignant?)
|
Composed of cell types derived from more than one germ layer
Can be benign or malignant |
|
Hamartoma (benign or malignant?)
|
Mass of normal but disorganized tissue indigenous to site of origin
Benign |
|
Heterotopia (benign or malignant?)
|
Ectopic rest of normal tissue
Benign |
|
Tumor suppressor genes (3)
|
Normall growth inhibiting
Both alleles must be lost Loss of heterozygosity -> cancer |
|
4 aspects of carcinogenesis
|
Carcinogen - agent which leads to increased incidence of neoplasms
Latency - time b/w exposure to carcinogen and neoplasm Initiation - acquisition of IRREVERSIBLE AND TRANSMISSIBLE genetic changes Promotion - REVERSIBLE biologic processes that favor neoplasm |
|
Neoplastic cell growth (proliferative pool and growth fraction)
|
Proliferative pool - drives tumor growth
Growth fraction: percent of tumor that is proliferative pool |
|
4 pathways of tumor spreading
|
Direct invasion
Lymphatic spread - carcinomas Hematogenous spread - sarcomas Seeding of body cavities |
|
Metaplasia
|
NOT pre neoplastic, but cancer can arise in metaplastic epithelium
|
|
Precursors to cancer
|
Pathologic hyperplasia - atypical hyperplasia and dysplasia
|
|
Dysplasia (3, for what systems?)
|
Disordered architecture of epithelium
Proliferative state BM still intact Genitourinary, GI, respiratory |
|
Carcinoma in situ
|
No maturation of cells from basal layer
Intact BM Leads to invasive squamous cell carcinoma |
|
Grading malignant neoplasms + differentiation
|
Well differentiated is lower grade than moderately differentiated
|
|
Carcinoma IHC
|
Cytokeratin
|
|
Lymphoma IHC
|
Leukocyte common antigen
|
|
Melanoma IHC
|
S-100
|
|
Tumor staging
|
T - site and extent of primary tumor
N - involvement of regional lymph nodes M - distant metastases |
|
Mechanisms of edema (5)
|
Increased hydrostatic pressure (CHF)
Decreased oncotic pressure (liver failure/hypoproteinemia) Lymphatic obstruction (metastatic cancer) Increased vascular permeability (inflammation) Sodium retention |
|
What does right heart failure cause?
|
Lower extremity edema
|
|
What does left heart failure cause?
|
Pulmonary edema
|
|
What causes exudate vs transudate?
|
Transudate - increased hydrostatic pressure
Exudate - inflammation or malignancy |
|
Transudate vs exudate
|
Transudate - clear, low cell count, benign
Exudate - turbid, high cell count, inflammatory/malignant |
|
Presentation of ischemia
|
Functional deficits heralded by pain (no morphologic changes in organ)
Eg: angina pectoris is caused by ischemia |
|
How can a person w/ CAD develop an infart?
|
Thrombosis -> vessel occlusion -> myocardial infarct
|
|
Pale/anemic vs red/hemorrhagic infarcts (3)
|
Pale - occlusion of end artery (spleen, heart, kidney)
Red - when tissue is congested at time of necrosis (CHF) or in organs w/ double blood supply (intestine and lung) or organs w/ more space for escape of blood (testes) |
|
Gangrene (wet vs dry)
|
Infarct affecting whole body part
Normally dry, if anaerobic putrefactive bacteria invade lesion -> wet |
|
Hemostasis vs thrombosis
|
Hemostasis - response to vascular injury -> formation of hemostatic plug to control hemorrhage
Thrombosis - pathology activation of hemostatic mechanisms in uninjured vessels |
|
Vitamin K dependent (for synthesis) coagulation factors
|
Factors II, VII, IX, X
Protein C and S |
|
Primary hemostatic plug (3)
|
Adhesion
Secretion Aggregation |
|
Coagulation factors synthesized in liver
|
All except von Willebrand Factor
|
|
Two most common causes of hereditary thrombophilia
|
1. Mutation in factor V gene (factor V Leiden)
2. Mutation in prothrombin gene |
|
How does aspirin inhibit platelet aggregation?
|
Inhibits thromboxane A2
|
|
What is the most important factor in thrombosis?
|
Endothelial injury
Exposure of subendothelial collagen tissue factor expression -> platelet adhesion and thrombus formation Endothelium need not be physically disrupted (eg smoke can lead to endothelial dysfunction) |
|
Hyperemia vs congestion
|
Hyperemia - active, increased blood flow
Congestion - passive, decreased blood flow |
|
Ischemia histology + morphology (4)
|
Contraction band necrosis - dissolution of cells -> infarct -> granulation tissue
No morphological features to organs upon presentation (usually just pain) |
|
Osteochondroma (Age, localization in bone and body)
|
During growth
Localized to physis (knee, prox humerus) |
|
Enchondroma (Age, localization in bone and body)
|
Wider age range
Most common in localized hand bones Metaphyseal or diaphyseal |
|
Osteoid osteoma (Age, localization in bone and body, radiographic signature)
|
During growth
Corticocentric in diaphysis Femur, tibia Sclerotic mature bone surrounding woven bone |
|
Giant cell tumor of bone (Age, localization in bone and body)
|
> 20 y.o
Epiphysis Knee Can produce soft tissue mass |
|
Osteosarcoma
|
Bimodal, during growth and in elderly
Metaphyseal intramedullary |
|
Chondrosarcoma (Age, localization in bone and body)
|
Middle-aged or older
Central skeleton Metaphyseal intramedullary |
|
Ewing sarcoma (Age, localization in bone and body, histological feature)
|
Small round tumor of childhood
Diaphyseal intramedullary Translocation Onion skin |
|
What condition can predispose to soft tissue tumor?
|
Neurofibromatosis type I (von Recklinghausen)
|
|
Adipose tumors
|
Lipoma - superficial
Liposarcoma - deep |
|
Diaphyseal intramedullary tumors
|
Ewing
Enchondroma |
|
Corticocentric diaphyseal tumors
|
Osteoid osteoma
|
|
Epiphyseal tumors
|
Giant cell tumor
|
|
Metaphyseal intramedullary
|
Osteosarcoma
Chondrosarcoma Enchondroma |
|
Atherosclerosis definition (what types of arteries are affected?)
|
Formation of intimal lipid rich fibrous plaques (commonly at bifurcation points)
Affects muscular and elastic arteries |
|
Composition of fatty streaks
|
Flat
Composed of lipid foam macrophages w/ T lymphocytes and extracellular lipid |
|
Intimal mass composition
|
Smooth muscles cells
Connective tissue NO lipids |
|
Components of atheromatous plaque (3)
|
Cells: smooth muscle, macrophage, lymphocytes
Connective tissue, ECM Intra/extracellular lipid deposits (fibrous cap and necrotic center) |
|
Response to injury hypothesis for atherosclerosis
|
Endothelial injury -> platelets -> inflammatory response -> foam cells
|
|
Non-modifiable risk factors for atherosclerosis
|
Age - older
Gender - men Genetic |